MetLife account proposes $15.5K sale of 160 shares

The prior-period sales table lists transactions dated August 20 through September 18, 2026.

Rhea-AI Filing Summary

MetLife Inc. (MET) has a Rule 144 notice listing a proposed sale of 160 common shares for the account of MetLife Separate Account SPI, with an aggregate market value of $15,500.80. Barclays is named as broker, and the approximate sale date is October 6, 2026, on the NYSE. The notice also lists prior-period sales by separate MetLife accounts and the MetLife 401k Plan Trust-Large Cap Equity Index.

Key Figures

Proposed shares: 160 shares Aggregate market value: $15,500.80 Prior sale shares: 244 shares +2 more

5 metrics

Proposed shares 160 shares MetLife Separate Account SPI; approximate sale date October 6, 2026

Aggregate market value $15,500.80 Proposed sale of 160 common shares

Prior sale shares 244 shares MetLife Separate Account SPI, August 20, 2026

Prior sale shares 104 shares Separate Account II, August 24, 2026

Prior sale shares 160 shares Separate Account II, August 28, 2026

Key Terms

Rule 144, Affiliate, person

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Affiliate regulatory

"Affiliate"

person regulatory

"definition of "person" in paragraph (a) of Rule 144"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MET shares are proposed for sale?

The notice lists 160 common shares for proposed sale, with an aggregate market value of $15,500.80. It gives an approximate sale date of October 6, 2026, and names Barclays as broker and the NYSE as exchange.

What earlier MET share sales are listed?

The prior-period table lists 244 shares for MetLife Separate Account SPI on August 20, 2026; 104 shares for Separate Account II on August 24; 160 shares for Separate Account II on August 28; and four entries dated September 18: 25 shares for Separate Account 149, 45 for Separate Account II, 224 for Separate Account SPI, and 266 for MetLife 401k Plan Trust-Large Cap Equity Index.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/06/2026 - 04:08 PM Accepted by SEC EDGAR 10/06/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000728618
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	METLIFE INC
SEC File Number
Address of Issuer	200 Park Avenue New York NEW YORK 10016
Phone	212-578-2211
Name of Person for Whose Account the Securities are To Be Sold	MetLife Separate Account SPI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays 745 Seventh Ave New York NY 10019	160	15500.8	635476927	10/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/29/2015	Purchase	GOLDMAN SACHS			160	06/03/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	08/20/2026	244	22804.24
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	08/24/2026	104	10005.84
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	08/28/2026	160	15441.6
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	09/18/2026	25	2426
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	09/18/2026	45	4366.8
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	09/18/2026	224	21736.96
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	09/18/2026	266	25812.64

144: Remarks and Signature

Remarks
Date of Notice	10/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mirsad Usejnoski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)